%0 Journal Article %A Davide Golinelli %A Erik Boetto %A Gherardo Carullo %A Maria Paola Landini %A Maria Pia Fantini %T How the COVID-19 pandemic is favoring the adoption of digital technologies in healthcare: a rapid literature review %D 2020 %R 10.1101/2020.04.26.20080341 %J medRxiv %P 2020.04.26.20080341 %X Background Healthcare is responding to the COVID-19 pandemic through the fast adoption of digital solutions and advanced technology tools. Many of the solutions implemented now could consolidate in the near future, contributing to the definition of new digital-based models of care. The aim of this study is to describe which digital solutions have been reported in the early scientific literature to respond and fight the COVID-19 pandemic.Methods We conducted a rapid literature review searching PubMed and MedrXiv with terms considered adequate to find relevant literature on the use of digital technologies in response to COVID-19.Results The search identified 52 articles, of which 38 full-text articles were assessed and 29 included in the review after screening. Of selected articles, most of them addressed the use of digital technologies for diagnosis, surveillance and prevention. We report that digital solutions and innovative technologies have mainly been proposed for the diagnosis of COVID-19. In particular, within the reviewed articles we identified numerous suggestions on the use of artificial intelligence-powered tools for the diagnosis and screening of COVID-19. Digital technologies are useful also for prevention and surveillance measures, for example through contact-tracing apps or monitoring of internet searches and social media usage.Discussion It is worth taking advantage of the push given by the crisis, and mandatory to keep track of the digital solutions proposed today to implement tomorrow’s best practices and models of care, and to be ready for any new moments of emergency.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A %U https://www.medrxiv.org/content/medrxiv/early/2020/05/01/2020.04.26.20080341.full.pdf